Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ybx1
|
ENSMUSG00000028639.8 | Y box protein 1 |
Nfya
|
ENSMUSG00000023994.7 | nuclear transcription factor-Y alpha |
Nfyb
|
ENSMUSG00000020248.12 | nuclear transcription factor-Y beta |
Nfyc
|
ENSMUSG00000032897.11 | nuclear transcription factor-Y gamma |
Cebpz
|
ENSMUSG00000024081.8 | CCAAT/enhancer binding protein zeta |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_78936752_78936930 | Cebpz | 196 | 0.606896 | -0.93 | 6.8e-03 | Click! |
chr17_78936499_78936728 | Cebpz | 424 | 0.506848 | -0.87 | 2.6e-02 | Click! |
chr17_48409521_48409683 | Nfya | 86 | 0.826877 | 0.85 | 3.4e-02 | Click! |
chr17_48408941_48409149 | Nfya | 643 | 0.466006 | 0.69 | 1.3e-01 | Click! |
chr17_48409735_48409904 | Nfya | 54 | 0.682916 | 0.66 | 1.6e-01 | Click! |
chr10_82758923_82759475 | Nfyb | 1892 | 0.234694 | 0.97 | 1.6e-03 | Click! |
chr10_82763951_82764143 | Nfyb | 54 | 0.959224 | 0.97 | 1.8e-03 | Click! |
chr10_82762050_82762252 | Nfyb | 1495 | 0.286842 | -0.95 | 3.4e-03 | Click! |
chr10_82757704_82757886 | Nfyb | 488 | 0.714282 | -0.93 | 7.3e-03 | Click! |
chr10_82742194_82742386 | Nfyb | 9369 | 0.127226 | -0.90 | 1.5e-02 | Click! |
chr4_120817489_120817655 | Nfyc | 1860 | 0.237899 | -0.95 | 3.2e-03 | Click! |
chr4_120799950_120800120 | Nfyc | 9554 | 0.119213 | -0.94 | 5.3e-03 | Click! |
chr4_120805342_120805549 | Nfyc | 10267 | 0.119290 | -0.94 | 5.9e-03 | Click! |
chr4_120815742_120815909 | Nfyc | 113 | 0.945899 | 0.94 | 6.1e-03 | Click! |
chr4_120805604_120805779 | Nfyc | 10021 | 0.119753 | -0.89 | 1.6e-02 | Click! |
chr4_119294549_119294710 | Ybx1 | 25 | 0.922160 | 0.88 | 2.0e-02 | Click! |
chr4_119293732_119293975 | Ybx1 | 627 | 0.497397 | 0.77 | 7.3e-02 | Click! |
chr4_119292793_119292981 | Ybx1 | 1593 | 0.201743 | -0.66 | 1.5e-01 | Click! |
chr4_119294177_119294328 | Ybx1 | 228 | 0.822509 | -0.52 | 2.9e-01 | Click! |
chr4_119294799_119294995 | Ybx1 | 293 | 0.644908 | -0.39 | 4.5e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_22439730_22439912 | 8.60 |
Etv5 |
ets variant 5 |
102 |
0.97 |
chr15_79062944_79063139 | 8.20 |
Ankrd54 |
ankyrin repeat domain 54 |
148 |
0.87 |
chr3_89418362_89418520 | 6.60 |
Shc1 |
src homology 2 domain-containing transforming protein C1 |
2 |
0.52 |
chr12_85113861_85114043 | 6.54 |
Dlst |
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) |
3059 |
0.14 |
chr15_103305267_103305425 | 6.53 |
Gm49482 |
predicted gene, 49482 |
4281 |
0.11 |
chr8_83955400_83955718 | 6.51 |
Asf1b |
anti-silencing function 1B histone chaperone |
52 |
0.7 |
chr11_58948705_58948871 | 6.49 |
H2bu2 |
H2B.U histone 2 |
132 |
0.88 |
chr6_70844237_70844401 | 6.46 |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
196 |
0.93 |
chr9_54917030_54917230 | 6.33 |
Hykk |
hydroxylysine kinase 1 |
153 |
0.94 |
chr11_121236990_121237164 | 6.31 |
Narf |
nuclear prelamin A recognition factor |
176 |
0.91 |
chr10_80824337_80824490 | 6.23 |
Oaz1 |
ornithine decarboxylase antizyme 1 |
2243 |
0.12 |
chr8_70212287_70212467 | 6.21 |
Slc25a42 |
solute carrier family 25, member 42 |
72 |
0.95 |
chr19_46598891_46599052 | 6.21 |
Wbp1l |
WW domain binding protein 1 like |
113 |
0.95 |
chr3_96240283_96240448 | 6.01 |
H2ac19 |
H2A clustered histone 19 |
89 |
0.74 |
chr13_36578559_36578752 | 5.89 |
Gm48767 |
predicted gene, 48767 |
2721 |
0.2 |
chr11_55469186_55469684 | 5.84 |
G3bp1 |
GTPase activating protein (SH3 domain) binding protein 1 |
250 |
0.86 |
chr11_68691760_68691919 | 5.84 |
Myh10 |
myosin, heavy polypeptide 10, non-muscle |
76 |
0.98 |
chr3_95625229_95625406 | 5.80 |
Ensa |
endosulfine alpha |
291 |
0.8 |
chr17_48409521_48409683 | 5.73 |
Nfya |
nuclear transcription factor-Y alpha |
86 |
0.83 |
chr16_30065187_30065349 | 5.60 |
Hes1 |
hes family bHLH transcription factor 1 |
72 |
0.97 |
chr10_127121171_127121328 | 5.59 |
Os9 |
amplified in osteosarcoma |
118 |
0.91 |
chr11_116024422_116024746 | 5.43 |
H3f3b |
H3.3 histone B |
70 |
0.95 |
chrX_73097052_73097231 | 5.43 |
Xlr3a |
X-linked lymphocyte-regulated 3A |
46 |
0.49 |
chr11_58954509_58954669 | 5.39 |
H2bu1-ps |
H2B.U histone 1, pseudogene |
77 |
0.34 |
chr12_70204505_70204662 | 5.36 |
Pygl |
liver glycogen phosphorylase |
2765 |
0.21 |
chr11_103966311_103966715 | 5.27 |
Arf2 |
ADP-ribosylation factor 2 |
226 |
0.94 |
chr8_69716956_69717136 | 5.13 |
Zfp869 |
zinc finger protein 869 |
63 |
0.96 |
chr1_165602062_165602354 | 5.12 |
Mpzl1 |
myelin protein zero-like 1 |
3545 |
0.14 |
chr16_38088752_38088916 | 5.11 |
Gsk3b |
glycogen synthase kinase 3 beta |
167 |
0.96 |
chr11_71019247_71019609 | 5.10 |
Derl2 |
Der1-like domain family, member 2 |
125 |
0.57 |
chr13_22035648_22035811 | 5.08 |
H2bc12 |
H2B clustered histone 12 |
141 |
0.46 |
chr2_30364018_30364333 | 5.06 |
Miga2 |
mitoguardin 2 |
58 |
0.94 |
chr3_95015459_95015796 | 5.04 |
4930481B07Rik |
RIKEN cDNA 4930481B07 gene |
2 |
0.68 |
chr6_141327276_141327440 | 5.04 |
Gm10400 |
predicted gene 10400 |
13195 |
0.24 |
chr19_24271400_24271562 | 5.01 |
Fxn |
frataxin |
6690 |
0.18 |
chr7_3644783_3645239 | 5.00 |
Gm15927 |
predicted gene 15927 |
124 |
0.64 |
chr15_98534278_98534434 | 4.97 |
Kansl2 |
KAT8 regulatory NSL complex subunit 2 |
92 |
0.92 |
chr16_38088933_38089112 | 4.95 |
Gsk3b |
glycogen synthase kinase 3 beta |
21 |
0.98 |
chr2_103485095_103485448 | 4.93 |
Cat |
catalase |
111 |
0.97 |
chr16_38089180_38089343 | 4.87 |
Gsk3b |
glycogen synthase kinase 3 beta |
260 |
0.94 |
chr5_34187928_34188104 | 4.85 |
Mxd4 |
Max dimerization protein 4 |
296 |
0.81 |
chr11_101682592_101683066 | 4.72 |
Arl4d |
ADP-ribosylation factor-like 4D |
17288 |
0.09 |
chr7_45459818_45459984 | 4.69 |
Ftl1 |
ferritin light polypeptide 1 |
17 |
0.82 |
chr1_23256022_23256191 | 4.69 |
Gm6420 |
predicted gene 6420 |
300 |
0.85 |
chr1_189688122_189688281 | 4.64 |
Cenpf |
centromere protein F |
115 |
0.96 |
chr5_93267087_93267273 | 4.62 |
Ccng2 |
cyclin G2 |
77 |
0.97 |
chr13_23621145_23621312 | 4.62 |
H2bc6 |
H2B clustered histone 6 |
104 |
0.57 |
chr7_4876897_4877066 | 4.59 |
Isoc2a |
isochorismatase domain containing 2a |
172 |
0.87 |
chr10_62578429_62578587 | 4.59 |
Kifbp |
kinesin family binding protein |
51 |
0.93 |
chr13_23746567_23746739 | 4.56 |
H2bc3 |
H2B clustered histone 3 |
81 |
0.52 |
chr17_25015903_25016069 | 4.52 |
Ift140 |
intraflagellar transport 140 |
99 |
0.64 |
chr13_51645091_51645262 | 4.51 |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
56 |
0.97 |
chr4_102049507_102049659 | 4.50 |
Gm12799 |
predicted gene 12799 |
456 |
0.83 |
chr3_96576772_96576955 | 4.50 |
Gm16253 |
predicted gene 16253 |
121 |
0.89 |
chr2_32137995_32138152 | 4.49 |
Prrc2b |
proline-rich coiled-coil 2B |
13009 |
0.11 |
chr11_69408665_69408843 | 4.48 |
Kdm6b |
KDM1 lysine (K)-specific demethylase 6B |
4539 |
0.09 |
chr15_78174169_78174404 | 4.47 |
Gm49694 |
predicted gene, 49694 |
175 |
0.49 |
chr10_99263084_99263251 | 4.47 |
Dusp6 |
dual specificity phosphatase 6 |
64 |
0.95 |
chr5_137601063_137601242 | 4.44 |
Mospd3 |
motile sperm domain containing 3 |
94 |
0.8 |
chr3_27153885_27154047 | 4.43 |
1700125G22Rik |
RIKEN cDNA 1700125G22 gene |
60 |
0.53 |
chr8_111300124_111300465 | 4.41 |
Rfwd3 |
ring finger and WD repeat domain 3 |
72 |
0.96 |
chr2_180273482_180273781 | 4.38 |
Cables2 |
CDK5 and Abl enzyme substrate 2 |
135 |
0.93 |
chr2_177032448_177032667 | 4.37 |
Gm14402 |
predicted gene 14402 |
98 |
0.95 |
chr9_113930805_113930974 | 4.37 |
Ubp1 |
upstream binding protein 1 |
45 |
0.98 |
chr5_147076546_147076702 | 4.37 |
Lnx2 |
ligand of numb-protein X 2 |
38 |
0.87 |
chr10_75893259_75893431 | 4.37 |
Derl3 |
Der1-like domain family, member 3 |
68 |
0.94 |
chr15_79063149_79063317 | 4.36 |
Ankrd54 |
ankyrin repeat domain 54 |
340 |
0.68 |
chr7_19149181_19149528 | 4.36 |
Qpctl |
glutaminyl-peptide cyclotransferase-like |
63 |
0.8 |
chr19_36769025_36769205 | 4.32 |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
32462 |
0.16 |
chr4_139622729_139622893 | 4.32 |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
55 |
0.96 |
chr13_23535164_23535321 | 4.27 |
H3c8 |
H3 clustered histone 8 |
180 |
0.74 |
chr10_76961990_76962153 | 4.27 |
Pcbp3 |
poly(rC) binding protein 3 |
184 |
0.94 |
chrX_20617503_20617850 | 4.26 |
Rbm10 |
RNA binding motif protein 10 |
54 |
0.49 |
chr16_22857712_22857877 | 4.24 |
Dnajb11 |
DnaJ heat shock protein family (Hsp40) member B11 |
51 |
0.59 |
chr13_34734657_34734990 | 4.21 |
Fam50b |
family with sequence similarity 50, member B |
27 |
0.96 |
chr15_80711041_80711202 | 4.20 |
Tnrc6b |
trinucleotide repeat containing 6b |
192 |
0.89 |
chr11_120727275_120727431 | 4.15 |
Dcxr |
dicarbonyl L-xylulose reductase |
72 |
0.91 |
chr13_113794402_113794570 | 4.13 |
Arl15 |
ADP-ribosylation factor-like 15 |
19 |
0.97 |
chr5_140830390_140830868 | 4.12 |
Gna12 |
guanine nucleotide binding protein, alpha 12 |
198 |
0.95 |
chr19_40581003_40581168 | 4.11 |
Aldh18a1 |
aldehyde dehydrogenase 18 family, member A1 |
7284 |
0.12 |
chr2_177173036_177173196 | 4.11 |
Gm14413 |
predicted gene 14413 |
246 |
0.89 |
chr1_131527355_131527727 | 4.10 |
Srgap2 |
SLIT-ROBO Rho GTPase activating protein 2 |
189 |
0.69 |
chr9_108578658_108578825 | 4.07 |
Wdr6 |
WD repeat domain 6 |
2 |
0.89 |
chr18_36744529_36744693 | 4.07 |
Ik |
IK cytokine |
45 |
0.49 |
chr2_25224743_25224915 | 4.06 |
Tubb4b |
tubulin, beta 4B class IVB |
127 |
0.85 |
chr19_4097136_4097298 | 4.06 |
Cdk2ap2 |
CDK2-associated protein 2 |
35 |
0.92 |
chr1_134099267_134099437 | 4.06 |
Gm38140 |
predicted gene, 38140 |
193 |
0.91 |
chr16_93822915_93823084 | 4.05 |
Morc3 |
microrchidia 3 |
9122 |
0.13 |
chr7_137411009_137411178 | 4.03 |
9430038I01Rik |
RIKEN cDNA 9430038I01 gene |
331 |
0.89 |
chr4_71668479_71668649 | 4.03 |
Gm11231 |
predicted gene 11231 |
9449 |
0.3 |
chr1_180196037_180196201 | 4.03 |
Coq8a |
coenzyme Q8A |
44 |
0.97 |
chr5_149053019_149053182 | 4.02 |
Hmgb1 |
high mobility group box 1 |
60 |
0.96 |
chr11_40733497_40733656 | 4.01 |
Nudcd2 |
NudC domain containing 2 |
91 |
0.59 |
chr13_3526432_3526596 | 4.00 |
Gdi2 |
guanosine diphosphate (GDP) dissociation inhibitor 2 |
11549 |
0.15 |
chr16_37539745_37539905 | 3.99 |
Gtf2e1 |
general transcription factor II E, polypeptide 1 (alpha subunit) |
36 |
0.52 |
chr7_44670891_44671049 | 3.99 |
Myh14 |
myosin, heavy polypeptide 14 |
127 |
0.92 |
chr3_61363728_61363891 | 3.98 |
Gm37696 |
predicted gene, 37696 |
1912 |
0.23 |
chr12_100187457_100187764 | 3.97 |
Gm10433 |
predicted gene 10433 |
358 |
0.62 |
chr11_40755282_40755440 | 3.95 |
Ccng1 |
cyclin G1 |
50 |
0.97 |
chr2_176830816_176830976 | 3.95 |
Gm14408 |
predicted gene 14408 |
244 |
0.91 |
chr5_146220962_146221121 | 3.95 |
Rnf6 |
ring finger protein (C3H2C3 type) 6 |
65 |
0.95 |
chr1_177441983_177442135 | 3.94 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
292 |
0.83 |
chr7_35056527_35056693 | 3.94 |
Cebpg |
CCAAT/enhancer binding protein (C/EBP), gamma |
37 |
0.89 |
chr15_78409558_78409738 | 3.93 |
Mpst |
mercaptopyruvate sulfurtransferase |
334 |
0.76 |
chr5_145204227_145204515 | 3.93 |
Zkscan5 |
zinc finger with KRAB and SCAN domains 5 |
191 |
0.88 |
chr19_4811622_4811779 | 3.92 |
Rbm14 |
RNA binding motif protein 14 |
66 |
0.51 |
chr18_34651722_34651884 | 3.91 |
Cdc23 |
CDC23 cell division cycle 23 |
68 |
0.95 |
chr2_91265079_91265247 | 3.91 |
Arfgap2 |
ADP-ribosylation factor GTPase activating protein 2 |
130 |
0.93 |
chr7_127573175_127573335 | 3.91 |
Phkg2 |
phosphorylase kinase, gamma 2 (testis) |
85 |
0.55 |
chr19_40513732_40513909 | 3.91 |
Sorbs1 |
sorbin and SH3 domain containing 1 |
41 |
0.97 |
chr4_43000361_43000681 | 3.90 |
Vcp |
valosin containing protein |
14 |
0.95 |
chr10_8071988_8072183 | 3.90 |
Gm48614 |
predicted gene, 48614 |
50793 |
0.15 |
chr4_118437339_118437511 | 3.90 |
Cdc20 |
cell division cycle 20 |
73 |
0.94 |
chr19_4793945_4794103 | 3.89 |
Rbm4 |
RNA binding motif protein 4 |
123 |
0.91 |
chr16_14317344_14317510 | 3.87 |
Fopnl |
Fgfr1op N-terminal like |
22 |
0.97 |
chrX_71555797_71555954 | 3.86 |
Hmgb3 |
high mobility group box 3 |
43 |
0.98 |
chr17_56008381_56008539 | 3.85 |
Mpnd |
MPN domain containing |
741 |
0.41 |
chr19_6241457_6241623 | 3.82 |
Atg2a |
autophagy related 2A |
128 |
0.9 |
chr16_42875409_42875605 | 3.82 |
4932412D23Rik |
RIKEN cDNA 4932412D23 gene |
80 |
0.83 |
chr5_30666702_30666866 | 3.80 |
Cenpa |
centromere protein A |
7 |
0.97 |
chr8_84237133_84237295 | 3.78 |
Zswim4 |
zinc finger SWIM-type containing 4 |
159 |
0.87 |
chr16_14163107_14163295 | 3.77 |
Nde1 |
nudE neurodevelopment protein 1 |
74 |
0.6 |
chr9_106892000_106892165 | 3.77 |
4930524O07Rik |
RIKEN cDNA 4930524O07 gene |
89 |
0.51 |
chr8_10908400_10908554 | 3.76 |
Gm2814 |
predicted gene 2814 |
7919 |
0.1 |
chr3_94953954_94954115 | 3.74 |
Rfx5 |
regulatory factor X, 5 (influences HLA class II expression) |
41 |
0.94 |
chr2_22589568_22589751 | 3.74 |
Gm13340 |
predicted gene 13340 |
12 |
0.93 |
chr9_57076088_57076313 | 3.73 |
Sin3a |
transcriptional regulator, SIN3A (yeast) |
176 |
0.92 |
chr5_137628625_137628972 | 3.73 |
Fbxo24 |
F-box protein 24 |
158 |
0.55 |
chr1_171502798_171503098 | 3.70 |
Gm24871 |
predicted gene, 24871 |
215 |
0.7 |
chr5_120516173_120516338 | 3.70 |
Slc8b1 |
solute carrier family 8 (sodium/lithium/calcium exchanger), member B1 |
3112 |
0.14 |
chr7_113207183_113207355 | 3.69 |
Arntl |
aryl hydrocarbon receptor nuclear translocator-like |
196 |
0.95 |
chr1_94469901_94470056 | 3.69 |
Gm7895 |
predicted gene 7895 |
91 |
0.98 |
chr19_11965500_11965673 | 3.69 |
Osbp |
oxysterol binding protein |
355 |
0.76 |
chr7_28392743_28392898 | 3.68 |
Med29 |
mediator complex subunit 29 |
112 |
0.51 |
chr1_64305426_64305825 | 3.68 |
Gm28981 |
predicted gene 28981 |
2582 |
0.36 |
chr11_20542749_20542918 | 3.68 |
Sertad2 |
SERTA domain containing 2 |
420 |
0.87 |
chr6_47813534_47813745 | 3.68 |
Pdia4 |
protein disulfide isomerase associated 4 |
209 |
0.87 |
chr19_23140696_23140859 | 3.67 |
Klf9 |
Kruppel-like factor 9 |
449 |
0.79 |
chr19_6046425_6046589 | 3.67 |
Syvn1 |
synovial apoptosis inhibitor 1, synoviolin |
69 |
0.88 |
chr2_127270026_127270209 | 3.67 |
Gm10766 |
predicted gene 10766 |
63 |
0.54 |
chr10_95426399_95426797 | 3.67 |
5730420D15Rik |
RIKEN cDNA 5730420D15 gene |
9223 |
0.12 |
chr5_134932216_134932383 | 3.65 |
Mettl27 |
methyltransferase like 27 |
69 |
0.9 |
chrX_73915015_73915351 | 3.65 |
Arhgap4 |
Rho GTPase activating protein 4 |
3847 |
0.12 |
chr10_82763951_82764143 | 3.62 |
Nfyb |
nuclear transcription factor-Y beta |
54 |
0.96 |
chr2_39190793_39190965 | 3.62 |
Scai |
suppressor of cancer cell invasion |
145 |
0.93 |
chr4_126019139_126019304 | 3.62 |
Csf3r |
colony stimulating factor 3 receptor (granulocyte) |
5329 |
0.17 |
chr14_47016165_47016374 | 3.62 |
Samd4 |
sterile alpha motif domain containing 4 |
14904 |
0.15 |
chr13_63063786_63063953 | 3.61 |
Aopep |
aminopeptidase O |
4246 |
0.21 |
chr2_34771806_34772017 | 3.61 |
Hspa5 |
heat shock protein 5 |
59 |
0.96 |
chr5_130144746_130144916 | 3.59 |
Kctd7 |
potassium channel tetramerisation domain containing 7 |
30 |
0.96 |
chr5_115158218_115158384 | 3.58 |
Mlec |
malectin |
122 |
0.93 |
chr13_23571200_23571368 | 3.56 |
H2ac8 |
H2A clustered histone 8 |
64 |
0.51 |
chr6_121110377_121110539 | 3.54 |
Mical3 |
microtubule associated monooxygenase, calponin and LIM domain containing 3 |
364 |
0.84 |
chr4_148591334_148591494 | 3.54 |
Srm |
spermidine synthase |
89 |
0.94 |
chr4_116720707_116720871 | 3.53 |
Tesk2 |
testis-specific kinase 2 |
159 |
0.92 |
chr14_47808473_47808625 | 3.52 |
Gm41148 |
predicted gene, 41148 |
3200 |
0.18 |
chr5_130144478_130144649 | 3.51 |
Kctd7 |
potassium channel tetramerisation domain containing 7 |
298 |
0.84 |
chr11_112782073_112782233 | 3.49 |
Sox9 |
SRY (sex determining region Y)-box 9 |
71 |
0.65 |
chr7_4866198_4866366 | 3.49 |
Isoc2b |
isochorismatase domain containing 2b |
89 |
0.92 |
chr5_143732437_143732610 | 3.47 |
Usp42 |
ubiquitin specific peptidase 42 |
243 |
0.91 |
chr3_82074661_82074828 | 3.46 |
Gucy1b1 |
guanylate cyclase 1, soluble, beta 1 |
55 |
0.98 |
chr5_121385602_121385771 | 3.45 |
Trafd1 |
TRAF type zinc finger domain containing 1 |
54 |
0.63 |
chr4_136310814_136310967 | 3.42 |
Hnrnpr |
heterogeneous nuclear ribonucleoprotein R |
52 |
0.96 |
chr3_95624833_95625010 | 3.41 |
Ensa |
endosulfine alpha |
72 |
0.94 |
chrX_7714564_7714721 | 3.41 |
Wdr45 |
WD repeat domain 45 |
309 |
0.74 |
chr2_11739723_11739874 | 3.41 |
Fbh1 |
F-box DNA helicase 1 |
3853 |
0.19 |
chr8_64733585_64733748 | 3.40 |
Msmo1 |
methylsterol monoxygenase 1 |
85 |
0.97 |
chr4_155361356_155361727 | 3.39 |
Prkcz |
protein kinase C, zeta |
180 |
0.93 |
chr8_123042192_123042343 | 3.38 |
Ankrd11 |
ankyrin repeat domain 11 |
10 |
0.71 |
chr6_124919755_124919923 | 3.38 |
Ptms |
parathymosin |
264 |
0.78 |
chr5_115559324_115559482 | 3.37 |
Rplp0 |
ribosomal protein, large, P0 |
64 |
0.94 |
chr3_69127059_69127221 | 3.37 |
Kpna4 |
karyopherin (importin) alpha 4 |
27 |
0.97 |
chr6_47595026_47595188 | 3.36 |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
49 |
0.97 |
chr13_23573784_23574438 | 3.36 |
H2bc7 |
H2B clustered histone 7 |
85 |
0.65 |
chr4_132515539_132515706 | 3.35 |
Sesn2 |
sestrin 2 |
5121 |
0.1 |
chr8_110970306_110970462 | 3.35 |
Ddx19a |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 19a |
10250 |
0.11 |
chr3_137864426_137864597 | 3.34 |
H2az1 |
H2A.Z variant histone 1 |
24 |
0.62 |
chr14_59440864_59441027 | 3.34 |
Cab39l |
calcium binding protein 39-like |
27 |
0.52 |
chr14_67715595_67715746 | 3.33 |
Cdca2 |
cell division cycle associated 2 |
11 |
0.79 |
chr12_110035272_110035439 | 3.33 |
Gm34667 |
predicted gene, 34667 |
11482 |
0.13 |
chr11_85352995_85353158 | 3.33 |
Bcas3 |
breast carcinoma amplified sequence 3 |
91 |
0.98 |
chr7_101607960_101608128 | 3.33 |
Art2b |
ADP-ribosyltransferase 2b |
22444 |
0.13 |
chr4_137389121_137389281 | 3.33 |
2810405F17Rik |
RIKEN cDNA 2810405F17 gene |
819 |
0.48 |
chr9_37208117_37208281 | 3.32 |
Tmem218 |
transmembrane protein 218 |
24 |
0.96 |
chr2_175110123_175110292 | 3.32 |
Gm14392 |
predicted gene 14392 |
192 |
0.91 |
chr11_70668821_70668980 | 3.32 |
Spag7 |
sperm associated antigen 7 |
318 |
0.7 |
chr13_34314574_34314734 | 3.31 |
Gm47086 |
predicted gene, 47086 |
4154 |
0.23 |
chr15_3995867_3996094 | 3.31 |
Gm2093 |
predicted gene 2093 |
59 |
0.73 |
chr10_80149457_80149621 | 3.30 |
Midn |
midnolin |
347 |
0.73 |
chr15_38300713_38300942 | 3.29 |
Klf10 |
Kruppel-like factor 10 |
121 |
0.95 |
chr19_6363500_6363671 | 3.29 |
Gm14966 |
predicted gene 14966 |
50 |
0.55 |
chr11_95041399_95041567 | 3.29 |
Pdk2 |
pyruvate dehydrogenase kinase, isoenzyme 2 |
129 |
0.93 |
chr8_84846955_84847140 | 3.28 |
Calr |
calreticulin |
113 |
0.52 |
chr15_16566506_16566694 | 3.28 |
Gm2611 |
predicted gene 2611 |
33962 |
0.19 |
chr4_132510488_132510645 | 3.28 |
Sesn2 |
sestrin 2 |
65 |
0.92 |
chrX_20364423_20364578 | 3.26 |
Rp2 |
retinitis pigmentosa 2 homolog |
19 |
0.97 |
chr5_23433330_23433488 | 3.25 |
5031425E22Rik |
RIKEN cDNA 5031425E22 gene |
73 |
0.94 |
chr19_7040189_7040358 | 3.25 |
Stip1 |
stress-induced phosphoprotein 1 |
306 |
0.79 |
chr11_115163166_115163335 | 3.24 |
Slc9a3r1 |
solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 |
91 |
0.95 |
chr12_8500012_8500175 | 3.23 |
Rhob |
ras homolog family member B |
84 |
0.96 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 14.2 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
2.8 | 8.4 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
2.6 | 7.8 | GO:0051182 | coenzyme transport(GO:0051182) |
2.1 | 6.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
2.1 | 2.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
1.9 | 5.8 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
1.9 | 9.4 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
1.8 | 9.2 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.8 | 5.3 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.7 | 6.9 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
1.7 | 5.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
1.7 | 5.0 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
1.6 | 4.8 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
1.5 | 12.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.5 | 12.2 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
1.5 | 6.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
1.4 | 7.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
1.4 | 5.5 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.3 | 3.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.3 | 3.9 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
1.3 | 7.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.3 | 5.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
1.2 | 6.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
1.2 | 7.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
1.2 | 2.4 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
1.2 | 3.6 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.2 | 4.7 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
1.1 | 3.4 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
1.1 | 3.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.1 | 6.7 | GO:0090166 | Golgi disassembly(GO:0090166) |
1.1 | 3.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.1 | 4.4 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
1.1 | 3.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.1 | 3.3 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
1.1 | 11.7 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
1.0 | 4.1 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.0 | 3.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
1.0 | 2.0 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
1.0 | 3.0 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
1.0 | 2.0 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
1.0 | 3.0 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.0 | 4.9 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
1.0 | 4.9 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
1.0 | 2.9 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.9 | 4.7 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.9 | 7.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.9 | 1.9 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.9 | 5.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.9 | 2.7 | GO:0000087 | mitotic M phase(GO:0000087) |
0.9 | 0.9 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.9 | 6.4 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.9 | 4.5 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.9 | 3.6 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.9 | 5.4 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.9 | 3.6 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.9 | 2.7 | GO:0015888 | thiamine transport(GO:0015888) |
0.9 | 3.6 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.9 | 5.3 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.9 | 4.4 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.9 | 3.4 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.9 | 2.6 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.8 | 2.5 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.8 | 0.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.8 | 1.7 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
0.8 | 2.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.8 | 3.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.8 | 2.4 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.8 | 1.6 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.8 | 3.2 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.8 | 3.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.8 | 2.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.8 | 1.6 | GO:0015755 | fructose transport(GO:0015755) |
0.8 | 2.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.8 | 5.4 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.8 | 3.9 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.8 | 5.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.8 | 2.3 | GO:0021564 | vagus nerve development(GO:0021564) |
0.8 | 3.8 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.8 | 3.8 | GO:1900094 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.7 | 2.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.7 | 3.0 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.7 | 2.2 | GO:0019086 | late viral transcription(GO:0019086) |
0.7 | 2.2 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.7 | 4.3 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.7 | 1.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.7 | 2.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.7 | 2.8 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.7 | 12.0 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.7 | 0.7 | GO:0019661 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.7 | 2.8 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.7 | 6.9 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.7 | 2.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.7 | 4.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.7 | 2.7 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.7 | 2.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.7 | 2.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.7 | 2.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.7 | 9.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.7 | 2.7 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.7 | 2.7 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.7 | 0.7 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.7 | 2.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.7 | 2.0 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.7 | 2.7 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.7 | 2.0 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.7 | 3.3 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.7 | 2.6 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.7 | 2.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.7 | 0.7 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.6 | 1.9 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.6 | 3.2 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.6 | 0.6 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.6 | 1.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.6 | 0.6 | GO:0002894 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.6 | 3.8 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.6 | 0.6 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.6 | 2.5 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.6 | 4.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.6 | 0.6 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.6 | 2.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.6 | 1.8 | GO:0040031 | snRNA modification(GO:0040031) |
0.6 | 2.4 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.6 | 2.4 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
0.6 | 11.0 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) mitotic G1/S transition checkpoint(GO:0044819) |
0.6 | 1.8 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.6 | 3.0 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.6 | 1.8 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.6 | 2.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.6 | 3.6 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.6 | 2.4 | GO:0019230 | proprioception(GO:0019230) |
0.6 | 1.8 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.6 | 4.2 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.6 | 2.4 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.6 | 1.8 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.6 | 1.8 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.6 | 3.5 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.6 | 2.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.6 | 2.3 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.6 | 1.2 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.6 | 1.7 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.6 | 2.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.6 | 2.3 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.6 | 2.9 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.6 | 1.1 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.6 | 2.3 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.6 | 6.9 | GO:0034030 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.6 | 0.6 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.6 | 0.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.6 | 2.8 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.6 | 2.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.6 | 5.0 | GO:0009650 | UV protection(GO:0009650) |
0.6 | 1.7 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.6 | 1.7 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.5 | 1.6 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.5 | 1.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.5 | 0.5 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.5 | 1.6 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.5 | 1.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.5 | 1.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.5 | 6.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.5 | 1.6 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.5 | 1.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.5 | 4.2 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.5 | 1.0 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.5 | 2.1 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.5 | 2.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.5 | 1.5 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.5 | 1.0 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.5 | 1.5 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.5 | 3.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.5 | 8.6 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.5 | 2.0 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.5 | 1.0 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.5 | 19.9 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.5 | 1.5 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.5 | 4.9 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
0.5 | 2.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.5 | 2.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.5 | 1.5 | GO:0060437 | lung growth(GO:0060437) |
0.5 | 1.5 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.5 | 1.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.5 | 8.3 | GO:0044804 | nucleophagy(GO:0044804) |
0.5 | 1.0 | GO:0051031 | tRNA transport(GO:0051031) |
0.5 | 4.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.5 | 1.5 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.5 | 0.5 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.5 | 2.4 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.5 | 0.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.5 | 2.4 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.5 | 1.0 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.5 | 1.4 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.5 | 2.4 | GO:0001842 | neural fold formation(GO:0001842) |
0.5 | 1.4 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.5 | 5.7 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.5 | 0.9 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.5 | 1.9 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.5 | 0.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.5 | 2.8 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.5 | 1.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.5 | 6.0 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.5 | 1.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.5 | 0.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.5 | 6.9 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.5 | 2.3 | GO:0090383 | phagosome acidification(GO:0090383) |
0.5 | 3.6 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.5 | 1.4 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.5 | 1.4 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.5 | 2.7 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.5 | 3.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.5 | 0.5 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.4 | 1.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.4 | 0.9 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.4 | 0.9 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.4 | 1.3 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.4 | 1.3 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.4 | 0.9 | GO:0003166 | bundle of His development(GO:0003166) |
0.4 | 5.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.4 | 1.8 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.4 | 1.3 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.4 | 10.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.4 | 1.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 | 1.7 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.4 | 1.7 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.4 | 1.7 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.4 | 1.7 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.4 | 2.2 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.4 | 1.3 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) hydrogen sulfide biosynthetic process(GO:0070814) |
0.4 | 0.9 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.4 | 1.3 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.4 | 0.4 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
0.4 | 3.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 1.7 | GO:0015886 | heme transport(GO:0015886) |
0.4 | 0.8 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.4 | 1.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 0.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.4 | 0.8 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.4 | 7.0 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.4 | 3.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.4 | 0.8 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.4 | 0.4 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.4 | 0.8 | GO:0001941 | postsynaptic membrane organization(GO:0001941) |
0.4 | 2.0 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.4 | 0.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.4 | 2.4 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.4 | 2.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.4 | 0.4 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.4 | 2.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.4 | 1.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.4 | 0.8 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.4 | 3.2 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.4 | 2.0 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.4 | 1.6 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.4 | 2.0 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.4 | 2.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.4 | 0.8 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.4 | 2.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.4 | 0.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.4 | 1.9 | GO:0009642 | response to light intensity(GO:0009642) |
0.4 | 0.4 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.4 | 0.8 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.4 | 3.8 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.4 | 2.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.4 | 1.9 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.4 | 0.4 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.4 | 2.7 | GO:0070986 | left/right axis specification(GO:0070986) |
0.4 | 6.5 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.4 | 1.1 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.4 | 4.2 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.4 | 3.4 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.4 | 1.9 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.4 | 1.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.4 | 4.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.4 | 1.9 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.4 | 1.9 | GO:0033504 | floor plate development(GO:0033504) |
0.4 | 1.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.4 | 1.1 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.4 | 0.4 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.4 | 1.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.4 | 3.3 | GO:0016556 | mRNA modification(GO:0016556) |
0.4 | 1.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 1.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.4 | 11.7 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.4 | 2.2 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.4 | 7.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.4 | 0.7 | GO:0030242 | pexophagy(GO:0030242) |
0.4 | 2.9 | GO:0002934 | desmosome organization(GO:0002934) |
0.4 | 0.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.4 | 1.4 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.4 | 0.7 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.4 | 1.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.4 | 4.6 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.4 | 1.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.4 | 0.4 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 1.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.4 | 5.0 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.4 | 3.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.4 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 2.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.3 | 2.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.3 | 1.0 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.3 | 1.0 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.3 | 1.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.3 | 1.0 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.3 | 3.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.3 | 1.0 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 1.0 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.3 | 1.4 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.3 | 1.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.3 | 1.0 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.3 | 7.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 1.0 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.3 | 1.0 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.3 | 0.7 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.3 | 1.7 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 1.0 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.3 | 1.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.3 | 1.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.3 | 0.3 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.3 | 2.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 1.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.3 | 3.9 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.3 | 3.2 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.3 | 0.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 1.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 1.0 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.3 | 1.0 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 1.9 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.3 | 0.3 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.3 | 0.3 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.3 | 0.9 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.3 | 0.6 | GO:0030578 | PML body organization(GO:0030578) |
0.3 | 0.6 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.3 | 0.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.3 | 0.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 0.6 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.3 | 3.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.3 | 0.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.3 | 1.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.3 | 2.4 | GO:0045176 | apical protein localization(GO:0045176) |
0.3 | 2.4 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.3 | 1.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 0.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 1.8 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.3 | 0.9 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.3 | 0.9 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.3 | 1.8 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.3 | 0.9 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.3 | 2.4 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.3 | 2.4 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.3 | 3.0 | GO:0035384 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.3 | 0.9 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.3 | 1.5 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.3 | 1.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.3 | 0.9 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 1.2 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.3 | 0.3 | GO:1903311 | regulation of mRNA metabolic process(GO:1903311) |
0.3 | 1.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 1.7 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 1.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 0.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 1.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.3 | 0.6 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.3 | 0.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.3 | 0.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 1.4 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.3 | 0.9 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.3 | 2.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.3 | 0.6 | GO:0072718 | response to cisplatin(GO:0072718) |
0.3 | 1.1 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.3 | 0.6 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.3 | 1.7 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.3 | 0.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.3 | 5.9 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 1.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.3 | 0.8 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.3 | 3.6 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.3 | 3.1 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.3 | 2.2 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.3 | 2.5 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.3 | 1.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.3 | 0.8 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.3 | 0.8 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.3 | 0.6 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.3 | 1.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 0.3 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.3 | 1.9 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.3 | 9.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.3 | 0.3 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.3 | 1.1 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.3 | 0.5 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.3 | 1.4 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.3 | 1.9 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.3 | 1.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.3 | 0.3 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.3 | 0.8 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.3 | 1.9 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 0.3 | GO:0009838 | abscission(GO:0009838) |
0.3 | 0.8 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.3 | 2.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.3 | 2.1 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.3 | 1.1 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.3 | 1.8 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.3 | 0.8 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.3 | 1.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 2.4 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.3 | 0.8 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.3 | 0.5 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.3 | 2.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 0.3 | GO:0051794 | regulation of catagen(GO:0051794) |
0.3 | 0.5 | GO:0045472 | response to ether(GO:0045472) |
0.3 | 1.0 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.3 | 1.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.3 | 2.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.3 | 1.3 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.3 | 0.8 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.3 | 0.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 0.5 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.3 | 0.5 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.3 | 1.8 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.3 | 1.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.3 | 1.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.3 | 0.3 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.2 | 5.2 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.2 | 1.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 1.7 | GO:1904869 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.2 | 0.5 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.2 | 0.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.2 | 0.2 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.2 | 2.5 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 2.5 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 1.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 2.0 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.2 | 0.2 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 2.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.2 | 0.2 | GO:0043586 | tongue development(GO:0043586) |
0.2 | 0.5 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 0.5 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.2 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 1.2 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.2 | 1.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.7 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.2 | 1.0 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 1.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 0.2 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 0.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.2 | 0.7 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.2 | 1.2 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.2 | 0.5 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.2 | 3.4 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.2 | 0.7 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 1.0 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 0.2 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
0.2 | 0.2 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.2 | 0.7 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.2 | 1.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.7 | GO:2000774 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.2 | 0.7 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.7 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.2 | 4.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.5 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.2 | 0.2 | GO:0097050 | type B pancreatic cell apoptotic process(GO:0097050) regulation of type B pancreatic cell apoptotic process(GO:2000674) positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.2 | 1.4 | GO:0007143 | female meiotic division(GO:0007143) |
0.2 | 1.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 1.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 0.7 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.2 | 2.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 2.5 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.2 | 0.7 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 0.7 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 1.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.9 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.2 | 0.5 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.2 | 0.5 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.2 | 1.1 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 0.2 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.2 | 0.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 0.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.2 | 0.2 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
0.2 | 0.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.2 | 0.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 0.4 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 5.5 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
0.2 | 4.0 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 1.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 0.9 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.2 | 3.1 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.7 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.2 | 2.9 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.2 | 0.7 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 0.7 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 0.4 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.2 | 0.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.2 | 0.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.2 | 0.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 1.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 2.8 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 0.4 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.2 | 0.6 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.2 | 2.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 0.8 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.4 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 1.0 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 0.2 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.2 | 1.0 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.2 | 1.0 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 5.0 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 0.6 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.2 | 3.1 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.2 | 0.6 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.2 | 0.2 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.2 | 1.8 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.2 | 0.8 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.2 | 0.8 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 1.2 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.2 | 0.8 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.2 | 1.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 4.6 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.2 | 2.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 0.2 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.2 | 0.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.2 | 0.8 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.2 | 0.2 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.2 | 0.6 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.2 | 1.4 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.2 | 0.6 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.2 | 0.4 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.2 | 1.0 | GO:1904356 | regulation of telomere maintenance via telomere lengthening(GO:1904356) |
0.2 | 1.9 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.2 | 1.2 | GO:0002467 | germinal center formation(GO:0002467) |
0.2 | 0.2 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.2 | 0.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 1.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 1.0 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.2 | 2.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 3.2 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.4 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.2 | 1.5 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.2 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.2 | 0.8 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.2 | GO:0010226 | response to lithium ion(GO:0010226) |
0.2 | 0.6 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.2 | 0.4 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.2 | 1.5 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.2 | 0.6 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.2 | 2.6 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.2 | 0.7 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.2 | 0.6 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.2 | 0.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 1.5 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 | 1.3 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.2 | 0.5 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.2 | 0.2 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.2 | 1.3 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.2 | 0.2 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.2 | 1.8 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 0.9 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
0.2 | 0.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.2 | 1.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 0.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 0.7 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.2 | 0.5 | GO:0051181 | cofactor transport(GO:0051181) |
0.2 | 0.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 5.0 | GO:0042073 | intraciliary transport(GO:0042073) |
0.2 | 2.3 | GO:0060074 | synapse maturation(GO:0060074) |
0.2 | 2.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 1.2 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.2 | 0.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 2.0 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.2 | 0.2 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.2 | 1.4 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.2 | 0.9 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.2 | 0.9 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.2 | 0.9 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 9.3 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.2 | 2.1 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.2 | 1.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 0.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 0.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.2 | 1.6 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.2 | 0.2 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 0.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.2 | 0.3 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.2 | 0.3 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 5.3 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.2 | 2.8 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.2 | 0.9 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.2 | 0.2 | GO:1904429 | regulation of t-circle formation(GO:1904429) |
0.2 | 0.3 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.2 | 0.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 1.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.2 | 0.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 0.2 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.2 | 2.9 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 0.9 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 0.3 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.2 | 2.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 0.8 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.2 | 1.0 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 0.3 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.2 | 0.5 | GO:0006560 | proline metabolic process(GO:0006560) |
0.2 | 0.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 1.7 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.2 | 1.7 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 0.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 0.8 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 0.5 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.2 | 0.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 0.7 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.2 | 2.5 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 0.5 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.2 | 5.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.2 | 1.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.8 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.2 | 0.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.2 | 2.0 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 0.3 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 1.6 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.2 | 0.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.2 | 2.1 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.2 | 0.3 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.2 | 0.5 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 4.2 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.2 | 1.9 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 0.3 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.2 | 3.4 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.2 | 0.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 52.8 | GO:0051301 | cell division(GO:0051301) |
0.2 | 0.3 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.2 | 3.9 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 0.3 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 5.9 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.2 | 0.6 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.2 | 3.0 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.2 | 0.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 0.5 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.6 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 1.2 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 2.5 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 0.3 | GO:0032206 | positive regulation of telomere maintenance(GO:0032206) |
0.2 | 0.8 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 1.9 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 0.6 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.2 | 0.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.6 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 0.5 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.2 | 0.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 2.4 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.2 | 0.2 | GO:0051985 | negative regulation of chromosome segregation(GO:0051985) |
0.2 | 0.5 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.2 | 5.3 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.2 | 0.5 | GO:0031100 | organ regeneration(GO:0031100) |
0.2 | 0.6 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.2 | 0.8 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.2 | 0.8 | GO:0061053 | somite development(GO:0061053) |
0.1 | 0.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.6 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 1.2 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 1.0 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 1.5 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 0.3 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.3 | GO:0021914 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.3 | GO:0071865 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.1 | 0.3 | GO:0060487 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
0.1 | 0.4 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.4 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.1 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.1 | 1.6 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.6 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.3 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 2.3 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.9 | GO:0032147 | activation of protein kinase activity(GO:0032147) |
0.1 | 0.1 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.1 | 0.7 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.3 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 0.9 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.1 | 0.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.3 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 1.8 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.1 | 0.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.6 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
0.1 | 4.6 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 1.5 | GO:0006582 | melanin metabolic process(GO:0006582) |
0.1 | 0.3 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.7 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.1 | GO:1900044 | histone H2A K63-linked ubiquitination(GO:0070535) regulation of protein K63-linked ubiquitination(GO:1900044) negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 0.7 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 6.6 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.1 | 1.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 1.9 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.3 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.1 | 0.3 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.1 | 0.1 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.1 | 2.3 | GO:0098927 | vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 1.2 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.1 | 1.5 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.7 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.4 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.9 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.1 | 0.3 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 0.3 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 0.4 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 2.0 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.5 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.5 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 0.4 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
0.1 | 0.8 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.1 | 0.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 3.3 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 2.4 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.1 | 0.5 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.3 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.6 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.4 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.4 | GO:1904707 | regulation of vascular smooth muscle cell proliferation(GO:1904705) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) vascular smooth muscle cell proliferation(GO:1990874) |
0.1 | 0.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 2.0 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.1 | 0.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 1.5 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 1.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.6 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 1.7 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.7 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.7 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.2 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.1 | 0.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.5 | GO:0048242 | epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
0.1 | 0.5 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.1 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.8 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 2.5 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 3.0 | GO:0043113 | receptor clustering(GO:0043113) |
0.1 | 0.6 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.1 | 0.4 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.1 | 2.4 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.1 | 1.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 1.7 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 2.2 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.6 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 2.1 | GO:0061371 | determination of heart left/right asymmetry(GO:0061371) |
0.1 | 1.4 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.1 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.1 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 1.2 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.5 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 1.7 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 2.1 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.5 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.5 | GO:0048679 | regulation of axon regeneration(GO:0048679) |
0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 1.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.3 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.1 | 0.2 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.1 | 0.3 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 2.3 | GO:0006342 | chromatin silencing(GO:0006342) |
0.1 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 1.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.5 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 0.1 | GO:0036302 | ventricular compact myocardium morphogenesis(GO:0003223) atrioventricular canal development(GO:0036302) |
0.1 | 1.7 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.8 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 1.3 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 2.8 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 0.2 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.1 | 0.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 0.2 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 0.4 | GO:0051193 | regulation of cofactor metabolic process(GO:0051193) |
0.1 | 0.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.1 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.1 | 0.8 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 1.5 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.4 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.1 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.1 | 1.3 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.5 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 1.5 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 1.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.2 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 0.4 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.1 | 0.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.8 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.2 | GO:0021637 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
0.1 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 3.3 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.1 | 1.8 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.2 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 3.8 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.1 | 0.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.9 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 1.0 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.3 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 3.0 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 1.6 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.2 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) negative regulation of mRNA catabolic process(GO:1902373) |
0.1 | 0.3 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.5 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 1.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 1.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 1.6 | GO:0035306 | positive regulation of dephosphorylation(GO:0035306) |
0.1 | 0.7 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 2.5 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.5 | GO:0001656 | metanephros development(GO:0001656) |
0.1 | 0.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.6 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.7 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.1 | 0.5 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.1 | 2.2 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.6 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.8 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.7 | GO:1990090 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
0.1 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.2 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.1 | 0.4 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.1 | 1.4 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.2 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
0.1 | 0.3 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.3 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 0.1 | GO:0060324 | face development(GO:0060324) |
0.1 | 0.4 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.4 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 0.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 0.3 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.1 | 5.4 | GO:0051236 | establishment of RNA localization(GO:0051236) |
0.1 | 0.2 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 1.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 0.8 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 0.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.6 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 3.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 1.3 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.1 | 0.1 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 0.3 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 0.2 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.4 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.1 | 0.6 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.1 | 1.6 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.1 | 0.4 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.5 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.2 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.7 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.4 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.2 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.1 | 0.4 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 3.3 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.1 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.2 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
0.1 | 2.8 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.4 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.1 | 0.3 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 1.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.4 | GO:1901571 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.1 | 0.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.3 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 0.2 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.1 | 0.5 | GO:0042220 | response to cocaine(GO:0042220) |
0.1 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.2 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.1 | 0.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 1.6 | GO:0048041 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.1 | 1.2 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.3 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 0.2 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.1 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.1 | 0.2 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.1 | 0.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.2 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.2 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 1.0 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.2 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.5 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 1.8 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.1 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.1 | 0.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.3 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.1 | 0.4 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.8 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.3 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 1.2 | GO:0042596 | fear response(GO:0042596) |
0.1 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.2 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.2 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.2 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 0.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 0.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.5 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 1.4 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.1 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.9 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.1 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 3.1 | GO:0060538 | skeletal muscle organ development(GO:0060538) |
0.1 | 0.4 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.8 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.5 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 1.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.1 | GO:1904938 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.1 | 0.1 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.4 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.1 | GO:0003143 | embryonic heart tube morphogenesis(GO:0003143) |
0.1 | 0.4 | GO:0034204 | lipid translocation(GO:0034204) |
0.1 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.3 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.1 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
0.1 | 0.1 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.5 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 0.3 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.2 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 2.1 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 0.1 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.1 | 0.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.1 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
0.1 | 0.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.6 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 0.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.9 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.1 | 0.1 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.1 | 0.1 | GO:0071773 | response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.1 | 0.3 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 0.1 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.1 | 0.1 | GO:0003094 | glomerular filtration(GO:0003094) |
0.1 | 0.1 | GO:0072109 | glomerular mesangium development(GO:0072109) |
0.1 | 2.2 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 99.9 | GO:0006355 | regulation of transcription, DNA-templated(GO:0006355) |
0.1 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.8 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.1 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.1 | 0.3 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.1 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.1 | GO:0072505 | divalent inorganic anion homeostasis(GO:0072505) |
0.1 | 0.1 | GO:0072017 | distal tubule development(GO:0072017) |
0.1 | 0.3 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.1 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.1 | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
0.1 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.1 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
0.1 | 0.2 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.1 | 0.3 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.2 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.2 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.3 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.1 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.3 | GO:0001893 | maternal placenta development(GO:0001893) |
0.1 | 0.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.1 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.1 | 0.1 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.7 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 0.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 0.1 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
0.1 | 0.3 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 0.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.1 | 0.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 1.1 | GO:0043242 | negative regulation of protein complex disassembly(GO:0043242) negative regulation of protein depolymerization(GO:1901880) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.1 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.1 | 0.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.1 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
0.1 | 0.1 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.1 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.1 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.1 | 0.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.4 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 0.1 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.2 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.2 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.1 | 0.2 | GO:0009065 | glutamine family amino acid catabolic process(GO:0009065) |
0.1 | 0.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 1.0 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.0 | 0.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.0 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.3 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.0 | 0.2 | GO:0046456 | icosanoid biosynthetic process(GO:0046456) fatty acid derivative biosynthetic process(GO:1901570) |
0.0 | 0.1 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.1 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 3.1 | GO:0098780 | mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.2 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.0 | 0.2 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.2 | GO:0007595 | lactation(GO:0007595) |
0.0 | 0.0 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.0 | 0.3 | GO:0060411 | cardiac septum morphogenesis(GO:0060411) |
0.0 | 0.6 | GO:0045637 | regulation of myeloid cell differentiation(GO:0045637) |
0.0 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 1.0 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.0 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.1 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.0 | 0.2 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.3 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.2 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 1.9 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.0 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 1.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.9 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.0 | 0.0 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.0 | 0.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.0 | 0.0 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.0 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.0 | 0.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.1 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.0 | 0.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.3 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.0 | 0.7 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.0 | 0.3 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.0 | 0.1 | GO:0098751 | bone cell development(GO:0098751) |
0.0 | 0.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 2.4 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.2 | GO:0031103 | axon regeneration(GO:0031103) |
0.0 | 0.0 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.0 | GO:0001914 | regulation of T cell mediated cytotoxicity(GO:0001914) |
0.0 | 0.2 | GO:2001056 | positive regulation of cysteine-type endopeptidase activity(GO:2001056) |
0.0 | 0.4 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.0 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.1 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.0 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 1.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.1 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.0 | 0.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.2 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.5 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0018904 | ether metabolic process(GO:0018904) |
0.0 | 0.3 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 0.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.1 | GO:0006057 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.0 | 0.2 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.0 | 0.2 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.4 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.0 | 0.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.0 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.0 | 0.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.1 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.2 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.1 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.0 | 0.2 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.3 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.1 | GO:0009952 | anterior/posterior pattern specification(GO:0009952) |
0.0 | 0.1 | GO:0033273 | response to vitamin(GO:0033273) |
0.0 | 0.1 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.3 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.0 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.0 | 0.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.2 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.0 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.1 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.0 | GO:0046881 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.0 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.0 | 0.2 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.3 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.0 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.0 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.2 | GO:0001570 | vasculogenesis(GO:0001570) |
0.0 | 0.0 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.7 | GO:0060348 | bone development(GO:0060348) |
0.0 | 0.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 1.0 | GO:0043405 | regulation of MAP kinase activity(GO:0043405) |
0.0 | 0.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.0 | 0.1 | GO:0060425 | lung morphogenesis(GO:0060425) |
0.0 | 0.1 | GO:0032094 | response to food(GO:0032094) |
0.0 | 2.8 | GO:0051260 | protein homooligomerization(GO:0051260) |
0.0 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.1 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.0 | 0.1 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.0 | 0.1 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.0 | 0.0 | GO:0009798 | axis specification(GO:0009798) |
0.0 | 0.0 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.0 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.1 | GO:0032891 | negative regulation of organic acid transport(GO:0032891) |
0.0 | 0.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.0 | 0.1 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.1 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.0 | 0.1 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.0 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.0 | GO:0072537 | fibroblast activation(GO:0072537) |
0.0 | 0.0 | GO:0034123 | positive regulation of toll-like receptor signaling pathway(GO:0034123) |
0.0 | 0.0 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.0 | 0.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.1 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 1.6 | GO:0198738 | cell-cell signaling by wnt(GO:0198738) |
0.0 | 0.0 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.0 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.0 | 1.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:2000648 | positive regulation of stem cell proliferation(GO:2000648) |
0.0 | 0.1 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.0 | 0.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.0 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.0 | 2.2 | GO:0051604 | protein maturation(GO:0051604) |
0.0 | 0.0 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.0 | 1.0 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.0 | 0.0 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.0 | 0.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 1.3 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 0.1 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.2 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.0 | 0.0 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.0 | 0.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.1 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.1 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.0 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.0 | 0.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 3.5 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.1 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.0 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 0.0 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.0 | 0.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.0 | GO:0010574 | regulation of vascular endothelial growth factor production(GO:0010574) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.1 | GO:0001824 | blastocyst development(GO:0001824) |
0.0 | 0.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.0 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.9 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.0 | 0.0 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.0 | 0.0 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.0 | 0.0 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.0 | 0.0 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.1 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.0 | 0.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.0 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.0 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.0 | GO:0051135 | positive regulation of NK T cell activation(GO:0051135) regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.0 | 0.0 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.0 | 0.8 | GO:0017148 | negative regulation of translation(GO:0017148) |
0.0 | 0.0 | GO:0014831 | gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.0 | 0.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.1 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.0 | 0.0 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.0 | 0.1 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.0 | 0.2 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.0 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.0 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.0 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.0 | 0.1 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.0 | 0.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.1 | GO:0032200 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.0 | 0.1 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.0 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.0 | 0.0 | GO:0044546 | NLRP3 inflammasome complex assembly(GO:0044546) regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.0 | 0.0 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.1 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.0 | 0.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.1 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.0 | 0.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:0016441 | posttranscriptional gene silencing(GO:0016441) |
0.0 | 0.0 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.0 | GO:0001709 | cell fate determination(GO:0001709) |
0.0 | 0.1 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) |
0.0 | 0.0 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.0 | 0.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.0 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.0 | 0.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.0 | 0.1 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.0 | GO:0071385 | cellular response to glucocorticoid stimulus(GO:0071385) |
0.0 | 0.2 | GO:0048771 | tissue remodeling(GO:0048771) |
0.0 | 0.0 | GO:0031057 | negative regulation of histone modification(GO:0031057) |
0.0 | 0.0 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.0 | 0.0 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
0.0 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.0 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.0 | 0.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.0 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.0 | 0.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.0 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.1 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.0 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.0 | 0.0 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.0 | 0.0 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.0 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.0 | 0.0 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.0 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
0.0 | 0.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.0 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) |
0.0 | 0.0 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.0 | 0.0 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.0 | 0.1 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.0 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.0 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.1 | GO:0071435 | potassium ion export(GO:0071435) |
0.0 | 0.4 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0043368 | positive T cell selection(GO:0043368) |
0.0 | 0.0 | GO:0002583 | regulation of antigen processing and presentation of peptide antigen(GO:0002583) |
0.0 | 0.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.0 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.2 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.3 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.0 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.0 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.0 | 0.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.4 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.0 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.0 | GO:1903214 | regulation of protein targeting to mitochondrion(GO:1903214) |
0.0 | 0.0 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.0 | 0.0 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.0 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.0 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.0 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.5 | GO:0097513 | myosin II filament(GO:0097513) |
2.6 | 10.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
2.2 | 8.7 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
1.6 | 14.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
1.5 | 4.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.3 | 9.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.3 | 1.3 | GO:0043596 | nuclear replication fork(GO:0043596) |
1.2 | 4.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.1 | 5.7 | GO:0005638 | lamin filament(GO:0005638) |
1.1 | 13.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
1.0 | 5.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
1.0 | 2.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.0 | 2.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.9 | 3.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.9 | 2.7 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.9 | 3.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.9 | 6.8 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.9 | 2.6 | GO:1990923 | PET complex(GO:1990923) |
0.8 | 6.8 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.8 | 3.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.8 | 17.0 | GO:0045120 | pronucleus(GO:0045120) |
0.8 | 9.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.8 | 3.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.8 | 3.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.8 | 4.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.8 | 2.3 | GO:0097413 | Lewy body(GO:0097413) |
0.8 | 9.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.8 | 0.8 | GO:1990696 | USH2 complex(GO:1990696) |
0.7 | 2.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.7 | 2.2 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.7 | 5.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.7 | 2.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.7 | 2.8 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.7 | 2.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.7 | 1.4 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.7 | 4.8 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.7 | 3.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.7 | 11.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.7 | 5.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.7 | 13.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.6 | 7.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.6 | 2.6 | GO:0070876 | SOSS complex(GO:0070876) |
0.6 | 3.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.6 | 3.0 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.6 | 4.8 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.6 | 2.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.6 | 6.5 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.6 | 2.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.6 | 2.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.5 | 1.6 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.5 | 3.8 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.5 | 2.2 | GO:0098536 | deuterosome(GO:0098536) |
0.5 | 12.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.5 | 3.2 | GO:1990462 | omegasome(GO:1990462) |
0.5 | 3.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.5 | 5.8 | GO:0042555 | MCM complex(GO:0042555) |
0.5 | 3.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.5 | 2.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.5 | 1.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.5 | 5.5 | GO:0016580 | Sin3 complex(GO:0016580) |
0.5 | 1.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.5 | 0.5 | GO:0035061 | interchromatin granule(GO:0035061) |
0.5 | 5.0 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.5 | 1.5 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.5 | 4.4 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.5 | 4.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.5 | 6.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.5 | 0.5 | GO:0000811 | GINS complex(GO:0000811) |
0.5 | 3.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.5 | 5.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.5 | 4.6 | GO:0032039 | integrator complex(GO:0032039) |
0.5 | 5.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 7.0 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.4 | 2.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.4 | 5.2 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.4 | 1.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.4 | 9.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.4 | 3.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.4 | 1.7 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.4 | 7.2 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.4 | 1.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.4 | 7.0 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.4 | 1.9 | GO:0070695 | FHF complex(GO:0070695) |
0.4 | 2.7 | GO:0005688 | U6 snRNP(GO:0005688) |
0.4 | 0.4 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 3.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 5.5 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.4 | 3.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.4 | 2.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.4 | 1.8 | GO:0070820 | tertiary granule(GO:0070820) |
0.4 | 3.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 31.0 | GO:0030496 | midbody(GO:0030496) |
0.4 | 11.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 0.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.3 | 0.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 4.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.3 | 1.7 | GO:0061617 | MICOS complex(GO:0061617) |
0.3 | 2.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 1.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.3 | 0.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 3.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 0.3 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 1.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.3 | 11.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.3 | 1.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.3 | 1.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.3 | 2.8 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.3 | 0.9 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 4.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 0.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.3 | 1.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 1.8 | GO:0072687 | meiotic spindle(GO:0072687) |
0.3 | 1.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 0.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 2.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.3 | 1.8 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.3 | 1.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.3 | 1.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 2.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 2.0 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 1.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 2.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 2.0 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 1.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 0.8 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 0.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 5.7 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.3 | 0.8 | GO:0097452 | GAIT complex(GO:0097452) |
0.3 | 1.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.3 | 2.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 0.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 1.6 | GO:0031983 | vesicle lumen(GO:0031983) |
0.3 | 0.8 | GO:0036396 | MIS complex(GO:0036396) |
0.3 | 1.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.3 | 3.7 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.3 | 4.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 0.3 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 1.5 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.3 | 0.8 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 3.5 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 5.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 10.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 1.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 1.9 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 2.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 1.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 0.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 1.2 | GO:1990391 | DNA repair complex(GO:1990391) |
0.2 | 8.1 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 0.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 0.9 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 0.7 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 5.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 0.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 1.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 15.4 | GO:0034399 | nuclear periphery(GO:0034399) |
0.2 | 1.1 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 0.4 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 0.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 6.1 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 0.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.2 | 1.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 0.2 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.2 | 2.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 3.8 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 1.0 | GO:0005818 | aster(GO:0005818) |
0.2 | 1.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 1.0 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 9.6 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 68.2 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 0.6 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 3.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 14.2 | GO:0005814 | centriole(GO:0005814) |
0.2 | 1.0 | GO:0038201 | TOR complex(GO:0038201) |
0.2 | 0.4 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.2 | 1.6 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 0.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 2.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 1.4 | GO:0070187 | telosome(GO:0070187) |
0.2 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 0.8 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.2 | 1.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 9.5 | GO:0016605 | PML body(GO:0016605) |
0.2 | 0.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 1.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 3.4 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 0.6 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 2.0 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 2.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 1.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 0.2 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.2 | 0.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 1.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 5.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 0.4 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.2 | 7.6 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.2 | 1.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 5.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 1.4 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 4.6 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.2 | 5.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.2 | 1.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 0.2 | GO:0012506 | vesicle membrane(GO:0012506) |
0.2 | 2.3 | GO:0002102 | podosome(GO:0002102) |
0.2 | 1.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 14.3 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.2 | 0.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 1.0 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 1.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 2.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 0.6 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 0.8 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 1.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 0.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 0.6 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 2.7 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.2 | 1.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 6.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 0.8 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 0.6 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 0.6 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 5.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 4.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 4.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.4 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.1 | 0.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 16.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 0.7 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 1.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.8 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 4.8 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 180.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 2.1 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 3.7 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 7.1 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 1.7 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 0.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.7 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.1 | 12.4 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 13.2 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 1.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 101.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 3.5 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 1.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 2.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.1 | GO:0036452 | ESCRT complex(GO:0036452) |
0.1 | 0.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.6 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.5 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 2.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 7.6 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 1.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 14.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 6.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 1.1 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.7 | GO:0044432 | endoplasmic reticulum part(GO:0044432) |
0.1 | 0.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 7.6 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.7 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 6.8 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.4 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 2.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 1.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.7 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.4 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 0.6 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 1.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 2.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 7.2 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 10.0 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 0.1 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 4.0 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 1.1 | GO:0005901 | caveola(GO:0005901) |
0.1 | 1.1 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.3 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.1 | 1.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.5 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 0.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 11.7 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.1 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 1.4 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.4 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 190.6 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 5.2 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.3 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 7.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 4.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.3 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.1 | 0.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.3 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.1 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 7.4 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 3.9 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.2 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.5 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 1.0 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.0 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 22.2 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 0.3 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.2 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.1 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.9 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0012505 | endomembrane system(GO:0012505) |
0.0 | 15.3 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.0 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.1 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 72.8 | GO:0005622 | intracellular(GO:0005622) |
0.0 | 0.5 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 13.6 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.6 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.0 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 33.3 | GO:0016021 | integral component of membrane(GO:0016021) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.9 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
2.2 | 8.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.7 | 6.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.7 | 6.7 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.6 | 4.7 | GO:0004096 | catalase activity(GO:0004096) |
1.4 | 4.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.4 | 4.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.3 | 4.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.3 | 14.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.3 | 3.9 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
1.3 | 5.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.2 | 2.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.1 | 3.4 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
1.1 | 1.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
1.1 | 6.5 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
1.1 | 3.2 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
1.0 | 4.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.0 | 3.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
1.0 | 3.0 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
1.0 | 12.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
1.0 | 2.9 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.0 | 7.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.9 | 0.9 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.9 | 3.8 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.9 | 8.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.9 | 6.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.9 | 2.7 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.9 | 3.7 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.9 | 4.6 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.9 | 2.7 | GO:0004359 | glutaminase activity(GO:0004359) |
0.8 | 1.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.8 | 2.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.8 | 8.4 | GO:0015266 | protein channel activity(GO:0015266) |
0.8 | 19.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.8 | 3.3 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.8 | 3.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.8 | 0.8 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.7 | 2.2 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.7 | 3.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.7 | 3.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.7 | 8.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.7 | 2.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.7 | 2.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.7 | 2.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.7 | 2.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.7 | 9.5 | GO:0005521 | lamin binding(GO:0005521) |
0.7 | 0.7 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.7 | 2.0 | GO:0030519 | snoRNP binding(GO:0030519) |
0.7 | 2.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.7 | 2.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.7 | 4.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.7 | 4.6 | GO:0018642 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.7 | 2.0 | GO:0004103 | choline kinase activity(GO:0004103) |
0.6 | 4.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.6 | 3.2 | GO:0070728 | leucine binding(GO:0070728) |
0.6 | 2.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.6 | 0.6 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.6 | 8.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.6 | 1.8 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.6 | 6.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.6 | 3.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.6 | 1.8 | GO:0045340 | mercury ion binding(GO:0045340) |
0.6 | 6.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.6 | 1.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.6 | 1.8 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.6 | 4.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.6 | 1.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 2.9 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.6 | 1.7 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.6 | 2.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.6 | 1.7 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.6 | 2.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.6 | 2.8 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.6 | 2.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.5 | 6.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.5 | 1.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.5 | 2.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.5 | 1.6 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.5 | 2.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.5 | 1.6 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.5 | 3.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.5 | 1.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.5 | 1.5 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.5 | 5.6 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.5 | 4.6 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.5 | 3.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.5 | 1.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.5 | 1.5 | GO:0036033 | mediator complex binding(GO:0036033) |
0.5 | 1.5 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.5 | 0.5 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.5 | 1.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.5 | 1.0 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.5 | 1.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.5 | 2.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.5 | 2.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.5 | 2.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.5 | 1.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.5 | 7.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.5 | 5.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.5 | 0.5 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.5 | 2.8 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.5 | 1.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.5 | 2.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.5 | 1.9 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.5 | 4.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.5 | 0.9 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.5 | 2.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.5 | 3.6 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.4 | 4.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.4 | 0.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 2.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.4 | 1.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.4 | 3.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 9.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.4 | 1.3 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.4 | 1.7 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.4 | 2.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.4 | 1.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.4 | 2.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.4 | 4.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.4 | 0.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.4 | 0.8 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.4 | 1.7 | GO:0015232 | heme transporter activity(GO:0015232) |
0.4 | 0.8 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.4 | 0.8 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.4 | 1.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 2.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 1.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 8.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.4 | 4.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.4 | 1.6 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 1.6 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 2.0 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.4 | 3.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.4 | 2.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.4 | 1.6 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.4 | 1.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.4 | 3.6 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.4 | 0.8 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.4 | 2.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.4 | 10.1 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.4 | 1.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.4 | 0.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 4.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 2.6 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.4 | 1.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.4 | 1.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.4 | 4.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 4.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.4 | 1.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.4 | 2.9 | GO:0005536 | glucose binding(GO:0005536) |
0.4 | 1.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 0.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.4 | 2.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.4 | 7.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.4 | 0.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.4 | 4.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.4 | 5.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.4 | 0.7 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.3 | 2.8 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.3 | 0.3 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 1.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.3 | 7.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.3 | 1.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.3 | 0.7 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.3 | 20.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.3 | 1.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.3 | 1.0 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.3 | 2.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 4.0 | GO:0005542 | folic acid binding(GO:0005542) |
0.3 | 2.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 0.7 | GO:0043398 | HLH domain binding(GO:0043398) |
0.3 | 2.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 1.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.3 | 1.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 5.6 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.3 | 1.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 0.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 4.9 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.3 | 0.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 1.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.3 | 3.8 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.3 | 4.7 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.3 | 1.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 0.9 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.3 | 4.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.3 | 2.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 0.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.3 | 5.2 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 1.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.3 | 0.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.3 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 2.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 0.6 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.3 | 1.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 1.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 0.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.3 | 0.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.3 | 2.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.3 | 2.6 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.3 | 0.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 3.7 | GO:0010181 | FMN binding(GO:0010181) |
0.3 | 0.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 2.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 1.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.3 | 7.7 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 0.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.3 | 0.3 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 1.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 3.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 1.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.3 | 1.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 2.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 1.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 3.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 2.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 0.8 | GO:0046977 | TAP binding(GO:0046977) |
0.3 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 1.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.3 | 1.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.3 | 3.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.3 | 0.8 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 9.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.3 | 3.8 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.3 | 0.8 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.2 | 4.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.7 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 2.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.5 | GO:0030371 | translation repressor activity(GO:0030371) |
0.2 | 1.9 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 1.2 | GO:0004527 | exonuclease activity(GO:0004527) |
0.2 | 4.9 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 0.2 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.2 | 0.9 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 4.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 0.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 1.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 2.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 12.6 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 0.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 2.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 3.4 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.2 | 0.7 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 2.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 1.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 4.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 1.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 1.3 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.2 | 0.7 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.2 | 0.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 2.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 0.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 1.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.2 | 0.7 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 2.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 3.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 1.5 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.2 | 0.4 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 5.0 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 6.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 0.2 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.2 | 4.0 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 1.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 0.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 0.8 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 1.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 5.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 0.8 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 5.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 1.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 3.9 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 1.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 1.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 2.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 5.6 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.2 | 0.8 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.2 | 3.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 2.6 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 0.6 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.8 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.2 | 1.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 1.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 3.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 1.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.2 | 0.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 1.7 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.2 | 1.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 1.7 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.2 | 0.6 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 9.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 0.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 4.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 0.4 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 6.8 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 2.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 0.5 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.2 | 12.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.2 | 0.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 0.5 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 0.4 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.2 | 0.9 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.2 | 0.7 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 0.9 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 0.2 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.2 | 0.7 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.2 | 0.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.2 | 0.5 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.2 | 40.4 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 0.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 0.9 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 0.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 17.5 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 0.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 1.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 155.1 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.2 | 0.5 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 11.2 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.2 | 0.7 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 0.3 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.2 | 0.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 0.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 0.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.2 | 0.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 0.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 2.0 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.2 | 0.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.2 | 2.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 0.7 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.2 | 1.5 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.2 | 0.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 1.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 0.3 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 5.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 0.2 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.2 | 0.6 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 0.3 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.2 | 3.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 4.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 0.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 0.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 0.8 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.2 | 0.5 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 5.2 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 0.5 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.2 | 0.3 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.2 | 0.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 8.6 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.2 | 0.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 5.6 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.2 | 1.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 1.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.4 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 1.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 5.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 14.0 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.1 | 12.6 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.1 | 6.3 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.4 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.6 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 2.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.1 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 1.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.7 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 1.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 1.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 4.9 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 2.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.4 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 1.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.8 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 2.8 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 0.8 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 1.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 1.2 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 0.3 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 1.0 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 2.0 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 2.3 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 2.8 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.1 | 0.4 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.8 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 3.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 2.0 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 3.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 10.5 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.6 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 2.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 6.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 0.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 1.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 7.8 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 1.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 2.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 2.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.9 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.9 | GO:0018449 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 2.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 2.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.2 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 2.2 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 8.0 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.9 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 4.6 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 3.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 3.4 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.1 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.7 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 1.0 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 6.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.2 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 2.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 6.8 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 2.5 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.2 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.5 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.7 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.8 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 1.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 2.9 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 8.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.3 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 2.8 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.4 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 2.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.4 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.5 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 8.1 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.3 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 1.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.8 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 1.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.4 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.1 | 0.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 1.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.2 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 0.4 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 2.0 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.1 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 0.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 4.0 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.1 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 1.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.1 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.1 | 8.8 | GO:0019900 | kinase binding(GO:0019900) |
0.1 | 1.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 2.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 41.1 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 37.5 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 11.2 | GO:0043773 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.1 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 2.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 6.7 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 0.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 1.0 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.8 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.1 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 1.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.8 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.2 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 1.4 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.1 | 0.3 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 0.1 | GO:0031720 | haptoglobin binding(GO:0031720) hemoglobin alpha binding(GO:0031721) |
0.1 | 0.5 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 1.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 2.4 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 1.0 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.2 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.9 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.2 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.1 | 0.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 3.1 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.1 | 0.1 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.1 | 0.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.4 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 0.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.5 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 17.9 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
0.1 | 3.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.2 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 17.3 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.6 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.4 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 4.3 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.4 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.5 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 5.9 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.3 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.7 | GO:0015631 | tubulin binding(GO:0015631) |
0.0 | 0.2 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.7 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 3.3 | GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides(GO:0016818) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.0 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.0 | 0.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 1.3 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.2 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 1.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.0 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.0 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.0 | 0.2 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 1.3 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.0 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.4 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.1 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.5 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:0048029 | monosaccharide binding(GO:0048029) |
0.0 | 0.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.0 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.0 | 0.8 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.2 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.4 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.0 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.0 | GO:0051379 | epinephrine binding(GO:0051379) |
0.0 | 0.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.0 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.0 | 0.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.2 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.1 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.2 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.0 | GO:0032934 | sterol binding(GO:0032934) |
0.0 | 0.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.2 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.2 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.0 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.2 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.0 | 0.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.0 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.5 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.0 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 0.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.9 | GO:0019904 | protein domain specific binding(GO:0019904) |
0.0 | 0.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.0 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.0 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.0 | 0.0 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.0 | 0.1 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.0 | 0.0 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.0 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.0 | 0.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 18.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.0 | 1.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.7 | 5.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.7 | 7.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.7 | 24.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.5 | 6.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.5 | 6.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.5 | 18.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.4 | 24.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 2.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 3.0 | ST STAT3 PATHWAY | STAT3 Pathway |
0.4 | 5.6 | PID ATM PATHWAY | ATM pathway |
0.4 | 3.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 15.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.4 | 6.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.4 | 1.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 13.8 | PID FOXO PATHWAY | FoxO family signaling |
0.4 | 0.8 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.4 | 18.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.4 | 9.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.4 | 13.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.4 | 0.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 11.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.3 | 3.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 1.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 8.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 7.5 | PID INSULIN PATHWAY | Insulin Pathway |
0.3 | 2.3 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 6.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 2.5 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 3.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 7.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 3.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 9.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 10.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 0.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 4.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 1.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 5.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 1.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 4.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 0.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 0.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 5.3 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 4.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 6.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 1.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 17.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 3.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 5.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 3.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 2.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 8.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 0.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 1.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 3.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 6.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 1.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 2.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 3.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 2.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 5.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 2.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 0.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 2.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 1.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 3.9 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 2.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 2.6 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 1.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 3.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 2.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 2.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 1.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.4 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 2.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 0.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 2.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 16.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
1.4 | 27.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
1.3 | 6.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.2 | 9.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.8 | 3.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.8 | 12.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.7 | 2.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.7 | 7.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.7 | 1.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.6 | 15.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.6 | 9.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.6 | 8.8 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.6 | 5.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.6 | 3.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.6 | 3.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.6 | 6.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.5 | 5.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.5 | 5.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.5 | 1.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.5 | 7.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.5 | 4.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.5 | 0.5 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.5 | 12.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.5 | 4.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.5 | 10.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.5 | 5.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.5 | 18.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.4 | 7.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.4 | 5.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.4 | 7.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 4.7 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.4 | 6.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.4 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.4 | 1.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.4 | 10.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.4 | 8.0 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.4 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.4 | 3.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.4 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.4 | 9.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 6.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 3.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 14.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 2.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 1.9 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.3 | 6.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 3.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 2.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 5.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.3 | 3.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 7.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 3.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 3.9 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.3 | 4.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.3 | 3.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 2.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 6.1 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.3 | 5.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.3 | 3.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 2.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 3.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 1.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 3.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 3.5 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.2 | 3.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.2 | 2.0 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 6.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 4.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 3.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.2 | 6.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 2.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 1.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 2.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 2.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 0.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 5.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 1.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 2.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 1.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 2.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 2.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 18.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 2.6 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.2 | 4.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 4.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 2.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 3.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 1.2 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.2 | 5.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 1.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 1.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 1.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 0.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 2.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 2.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 1.8 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 0.9 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.2 | 1.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 0.5 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.2 | 15.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 2.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 2.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 15.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 1.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 0.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 1.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 2.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 2.9 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.2 | 1.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 1.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 8.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 2.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 5.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 1.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 2.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 4.9 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 12.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 3.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 1.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 6.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 8.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 1.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 2.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 2.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.5 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 5.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 4.9 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 13.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 2.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 1.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.2 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.1 | 0.5 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 1.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 0.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 8.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.6 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.1 | 1.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 1.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 2.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 10.6 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.9 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 2.3 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 1.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 0.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 2.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 1.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 0.2 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 2.7 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 0.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.8 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 0.2 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 0.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 4.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 1.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 2.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.8 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.6 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 0.9 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 0.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 0.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.1 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.1 | 0.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 0.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.1 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 0.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 1.1 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 1.9 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 1.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.0 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.0 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.9 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 1.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.1 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.0 | REACTOME SIGNALLING TO ERKS | Genes involved in Signalling to ERKs |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.1 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 0.1 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |